Target Healthcare REIT (LON:THRL – Get Free Report)‘s stock had its “hold” rating reaffirmed by Jefferies Financial Group in a research note issued to investors on Wednesday,London Stock Exchange reports. They presently have a GBX 101 price target on the stock. Jefferies Financial Group’s price target points to a potential downside of 10.30% from the stock’s previous close.
Target Healthcare REIT Stock Down 1.1%
Shares of THRL stock traded down GBX 1.20 during trading on Wednesday, reaching GBX 112.60. The company’s stock had a trading volume of 745,235 shares, compared to its average volume of 5,744,188. The business has a fifty day moving average price of GBX 109.66 and a 200-day moving average price of GBX 106.21. The company has a market cap of £698.39 million, a price-to-earnings ratio of 8.96, a price-to-earnings-growth ratio of 1.48 and a beta of 0.71. Target Healthcare REIT has a one year low of GBX 92 and a one year high of GBX 117.
Target Healthcare REIT Company Profile
Recommended Stories
- Five stocks we like better than Target Healthcare REIT
- The FTC Is Suing Hims & Hers Health—Here’s Why Investors Shouldn’t Panic
- 3 Stocks Taking Very Different Routes Through the Summer Rally
- Is ADM’s Rally Getting Ahead of Its Policy Tailwind?
- CoreWeave Powers Up: The Asia Infrastructure Grab
Receive News & Ratings for Target Healthcare REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Target Healthcare REIT and related companies with MarketBeat.com's FREE daily email newsletter.
